Detalhe da pesquisa
1.
Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL.
Blood
; 137(18): 2463-2480, 2021 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33227818
2.
Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples.
Prostate
; 82(5): 584-597, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35084050
3.
BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee.
Biol Blood Marrow Transplant
; 24(4): 641-648, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29242112
4.
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.
Proc Natl Acad Sci U S A
; 109(10): 3879-84, 2012 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22343534
5.
Dual role of signaling pathways in myeloma requires cell-type specific targeting of ligand-receptor interactions.
Blood Adv
; 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38603572
6.
Genomics of lymphoid malignancies reveal major activation pathways in lymphocytes.
J Autoimmun
; 45: 15-23, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23880067
7.
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering.
Sci Adv
; 9(30): eadd6997, 2023 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494448
8.
Regulatory Programs of B-cell Activation and Germinal Center Reaction Allow B-ALL Escape from CD19 CAR T-cell Therapy.
Cancer Immunol Res
; 10(9): 1055-1068, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35759797
9.
Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myeloma.
Leukemia
; 36(4): 1078-1087, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35027656
10.
A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma.
Oral Oncol
; 119: 105366, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34091189
11.
Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma.
Nat Cell Biol
; 23(11): 1199-1211, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34675390
12.
Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma.
Clin Cancer Res
; 27(23): 6432-6444, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34518309
13.
Tracking myeloma tumor DNA in peripheral blood.
Best Pract Res Clin Haematol
; 33(1): 101146, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32139012
14.
Comprehensive characterization of circulating and bone marrow-derived multiple myeloma cells at minimal residual disease.
Semin Hematol
; 55(1): 33-37, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29759150
15.
The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma.
Cell Rep
; 19(1): 218-224, 2017 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28380360
16.
The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications.
Clin Cancer Res
; 23(15): 3980-3993, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28428191
17.
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.
Nat Commun
; 8(1): 1324, 2017 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29109393
18.
Genetic interrogation of circulating multiple myeloma cells at single-cell resolution.
Sci Transl Med
; 8(363): 363ra147, 2016 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27807282
19.
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.
Cancer Cell
; 25(1): 91-101, 2014 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24434212
20.
An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.
Nat Genet
; 46(4): 364-70, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24584072